RxDoctor Payments Data

Donna Gardner

Nurse Practitioner · Ithaca, NYNPI 1821089517

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,975 of the $10,069 with a category attached, or 69.3%. Sanofi accounts for 73.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $7,315 and has fallen 97.7% since, to $168 in 2025. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,069in general payments, 2019–2025

Across 152 payments — averaging $66.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$7K
  • AstraZeneca$643
  • GSK$283
  • Takeda Pharmaceuticals U.S.A., Inc.$276
  • Novartis$214
  • Regeneron Healthcare Solutions, Inc.$184
  • plus $1K from 16 others

What the payments were for

  • Consulting fees$6,97569%
  • Speaking & faculty fees$1251%
  • Food & beverage$2,96929%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,069 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$33,623
Breo ElliptaFluticasone/Vilanterol15$7,178
Advair HfaFluticasone Propion/Salmeterol18$7,097
Arnuity ElliptaFluticasone Furoate17$4,629
Epinephrine13$4,062
Mometasone Furoate24$2,789
Albuterol Sulfate HfaAlbuterol Sulfate27$1,018
Desloratadine12$963
Fluticasone Propionate44$874
Levocetirizine Dihydrochloride42$807
Azelastine Hcl16$751
Ipratropium Bromide19$711
Montelukast Sodium30$434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$283$45,42964 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.

Other nurse practitioner in Ithaca

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →